Chek2 alterations in pediatric malignancy: a single-institution experience

HIGHLIGHTS

• who: Eman Abdelghani et al. from the Division of Hematology/Oncology/Blood and Marrow Transplantation, Nationwide Children`s Hospital, Columbus, OH, USA Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA have published the research work: CHEK2 Alterations in Pediatric Malignancy: A Single-Institution Experience, in the Journal: Cancers 2023, 15, 1649. of 30/06/2021
• what: The authors report on six pediatric patients diagnosed with malignancy or hematologic disease and subsequently observed to harbor germline CHEK2 alterations.
• future: Work is needed to determine if there are patterns of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.